The Improved Pathways for Breast Cancer Care in Bermuda

Exploring Bermuda's improved pathway for breast cancer care with Dr.Chris Fosker, Medical Director at Bermuda Cancer and Health Centre, shedding light on innovations and patient-centered approaches.

Dr Fosker is the Medical Director at Bermuda Cancer and Health Centre, where he oversees the medical care provided to patients across the Centre. He ensures that the centre provides high-quality, evidence-based care to its patients. In addition to his administrative role, Dr Fosker is a practising clinical oncologist who meets with patients and works closely with other healthcare professionals to develop treatment plans, coordinate care, and monitor patient outcomes.

Dr Fosker is highly qualified to treat cancer patients with radiation therapy, chemotherapy, molecular therapy, and immunotherapy. Before moving to Bermuda, he worked as a specialist at St James Institute of Oncology in Leeds, which is Europe’s largest purpose-built cancer centre. He has completed a Fellowship at Princess Margaret Hospital in Toronto and has published research in a number of clinical areas, as well as in medical education, service development, and health economics. Dr Fosker is also an experienced policy advisor, having worked for the Macmillan Cancer Charity and NHS England as a clinical advisor. He is the recipient of several awards, including the ‘RS Bush Award’ for academic excellence fromPrincess Margaret Hospital and the University of Toronto. Dr Fosker received a Bachelor ofScience in Genetics from the University of Leeds.

As a member of the senior management team, Dr Fosker provides strategic clinical directionfor the Centre. His extensive experience and expertise in oncology make him an invaluableasset to the team and to the patients who receive care at Bermuda Cancer and HealthCentre.

 

Sponsor – Lindo's Group of Companies